Abstract
The present study aimed to assess the value of pre-diabetes and pre-hypertension in predicting cardiovascular events. A population-based, cross-sectional survey was conducted, representing a large sample of the general Iranian population aged 35 years and older from the Isfahan Province and determined using a random, multistage cluster-sampling 10-year cohort. The five end points considered as study outcome were unstable angina (UA), acute occurrence of myocardial infarction (MI), sudden cardiac death (SCD), brain stroke and cardiovascular disease (CVD). Of the 6323 subjects scheduled for assessment of diabetes state 617 were diabetics and 712 were pre-diabetic. In addition, of these subjects, 1754 had hypertension and 2500 had pre-hypertension. Analysing only pre-hypertension, pre-diabetes and its combination and adjusted for gender and age variables, pre-hypertension and pre-diabetes status together, could only effectively predict occurrence of MI (hazard ratio (HR)=3.21, 95% confidence interval (CI): 1.06–9.76, P=0.04). In the same COX regression models, pre-hypertension status could predict UA and CVD occurrence (HR=2.94, 95% CI: 1.68–5.14, P<0.001 and HR=1.74, 95% CI: 1.23–2.47, P=0.002, respectively). However, pre-diabetes status could not predict any of these events after adjustment for gender and age. Our data provide valuable evidence of the triggering role of pre-hypertension and pre-diabetes together, on appearance and progression of MI even in healthy individuals and the significant predicting value of pre-hypertension on the occurrence of UA and CVD. In this regard, the value of pre-hypertension and pre-diabetes together, and the pre-hypertension state alone, are clearly superior to pre-diabetes state alone in predicting cardiovascular events.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Lewington S, Clarke R, Qizilbash N, Peto R, Collins R . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360: 1903–1913.
Zhang Y, Lee ET, Devereux RB, Yeh J, Best LG, Fabsitz RR . Prehypertension, diabetes, and cardiovascular disease risk in a population-based sample: the Strong Heart Study. Hypertension 2006; 47: 410–414.
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA . The Seventh Report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 2003; 289: 2560–2572.
Choi KM, Park HS, Han JH, Lee JS, Lee J, Ryu OH . Prevalence of prehypertension and hypertension in a Korean population: Korean National Health and Nutrition Survey 2001. J Hypertens 2006; 24: 1515–1521.
Garber AJ, Handelsman Y, Einhorn D, Bergman DA, Bloomgarden ZT, Fonseca V et al. Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocr Pract 2008; 14: 933–946.
Yarahmadi SH, Etemad K, Hazaveh AM, Azhang N . Urbanization and non-communicable risk factors in the capital city of 6 big provinces of Iran. Iran J Public Health. 2013; 42 (Supple1): 113–118.
DeFronzo RA, Abdul-Ghani M . Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am J Cardiol 2011; 108 (3 suppl): 3–24B.
Sarrafzadegan N, Talaei M, Sadeghi M, Kelishadi R, Oveisgharan S, Mohammadifard N et al. The Isfahan cohort study: rationale, methods and main findings. J Hum Hypertens 2011; 25 (9): 545–553.
Sarrafzadegan N, Talaei M, Kelishadi R, Toghianifar N, Sadeghi M, Oveisgharan S et al. The influenceof gender and place of residence on cardiovascular diseases and their risk factors. The Isfahan cohort study. Saudi Med J 2012; 33 (5): 533–540.
Talaei M, Sarrafzadegan N, Sadeghi M, Oveisgharan S, Marshall T, Thomas GN et al. Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study. Arch Iran Med 2013; 16 (3): 138–144.
Gharipour M, Sarrafzadegan N, Sadeghi M, Andalib E, Talaie M, Shafie D et al. Predictors of metabolic syndrome in the Iranian population: waist circumference, body mass index, or waist to hip ratio? Cholesterol 2013; 2013: 198384.
Barrett-Connor E, Giardina EGV, Gitt AK, Gudat U, Steinberg HO, Tschoepe D . Women and heart disease: the role of diabetes and hyperglycemia. Arch Intern Med 2004; 164: 934–942.
Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyorala K . Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and Other Societies on Coronary Prevention. Eur Heart J 1998; 19: 1434–1503.
Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M et al. Euro Heart Survey Investigators. The prevalence of abnormal glucose regulation in patients with CAD across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25: 1880–1890.
Chalmers J, MacMahon S, Mancia G, Whitworth J, Beilin L, Hansson L et al. 1999 World Health Organization-International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization. Clin Exp Hypertens 1999; 21: 1009–1060.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2008; 31 (Suppl 1): 55–60.
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2011; 34 (Suppl 1): S62–S69.
El-Din A, Erfan M, Kandeel W, Kamal S, El Banna R, Fouad W . Prevalence of pre-hypertension and hypertension in a sample of Egyptian adults and its relation to obesity. Australian J Basic Appl Sci 2012; 6 (13): 481–489.
Gupta AK, McGlone M, Greenway FL, Johnson WD . Prehypertension in disease-free adults: a marker for an adverse cardiometabolic risk profile. Hypertens Res 2010; 33 (9): 905–910.
Matar D, Frangieh AH, Abouassi S, Bteich F, Saleh A, Salame E et al. Prevalence, awareness, treatment, and control of hypertension in Lebanon. J Clin Hypertens (Greenwich) 2015; 17 (5): 381–388.
Ganguly SS, Al-Shafaee MA, Bhargava K, Duttagupta KK . Prevalence of prehypertension and associated cardiovascular risk profiles among prediabetic Omani adults. BMC Public Health 2008; 8: 108.
Satman I, Omer B, Tutuncu Y, Kalaca S, Gedik S, Dinccag N et alTURDEP-II Study Group. Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. Eur J Epidemiol 2013; 28 (2): 169–180.
Al-Azzawi O . Prevalence of prediabetes and metabolic syndrome and their association in an Iraqi sample. IOSR-JDMS 2015; 14 (9):10–16.
Bahijri SM, Jambi HA, Al Raddadi RM, Ferns G, Tuomilehto J . The prevalence of diabetes and prediabetes in the adult population of Jeddah, Saudi Arabia—a community-based survey. PLoS ONE 2016; 11 (4): e0152559.
Ghassibe-Sabbagh M, Deeb M, Salloum AK, Mouzaya F, Haber M, Al-Sarraj Y et al. Multivariate epidemiologic analysis of type 2 diabetes mellitus risks in the Lebanese population. Diabetol Metab Syndr 2014; 6 (1): 89.
Al-Shafaee MA, Bhargava K, Al-Farsi YM, Mcilvenny S, Al-Mandhari A, Al-Adawi S et al. Prevalence of pre-diabetes and associated risk factors in an adult Omani population. Int J Diab Dev Ctries 2011; 31 (3): 166–173.
Zhang FF, Al Hooti S, Al Zenki S, Alomirah H, Jamil KM, Rao A et al. Vitamin D deficiency is associated with high prevalence of diabetes in Kuwaiti adults: results from a national survey. BMC Public Health 2016; 16 (1): 100.
Bener A, Zirie M, Janahi IM, Al-Hamaq AO, Musallam M, Wareham NJ . Prevalence of diagnosed and undiagnosed diabetes mellitus and its risk factors in a population-based study of Qatar. Diabetes Res Clin Pract 2009; 84 (1): 99–106.
Stamler J, Vaccaro O, Neaton JD, Wentworth D . Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434–444.
Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M . Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229–234.
Unwin N, Shaw J, Zimmet P, Alberti KG . Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 2002; 19: 708–723.
Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW . Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab). Circulation 2007; 116: 151–157.
Brownlee M . Advanced protein glycosylation in diabetes and aging. Annu Rev Med 1995; 46: 223–234.
Inoguchi T, Battan R, Handler E, Sportsman JR, Heath W, King GL . Preferential elevation of protein kinase C isoform beta II and diacylglycerol levels in the aorta and heart of diabetic rats: differential reversibility to glycemic control by islet cell transplantation. Proc Natl Acad Sci USA 1992; 89: 11059–11063.
Baynes JW . Role of oxidative stress in development of complications in diabetes. Diabetes 1991; 40: 405–412.
Grundy SM . Pre-diabetes, metabolic syndrome, and cardiovascular risk. J Am Coll Cardiol 2012; 59: 635–643.
Ferrannini E, Gastaldelli A, Iozzo P . Pathophysiology of prediabetes. Med Clin North Am 2011; 95: 327–339.
DeFronzo RA, Abdul-Ghani M . Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose. Am J Cardiol 2011; 108 (3 Suppl): 3B–24B.
DeFronzo RA . Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and atherosclerosis. Neth J Med 1997; 50: 191–197.
Rana JS, Visser ME, Arsenault BJ, Despres JP, Stroes ES, Kastelein JJ et al. Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. Int J Cardiol 2010; 143: 299–404.
Sheu WH, Shieh SM, Fuh MM, Shen DD, Jeng CY, Chen YD et al. Insulin resistance, glucose in tolerance, and hyper insulinemia. Hypertriglyceridemia versus hypercholesterolemia. Arterioscler Thromb 1993; 13: 367–370.
Qureshi AI, Suri MF, Kirmani JF, Divani AA, Mohammad Y . Is prehypertension a risk factor for cardiovascular diseases? Stroke 2005; 36: 1859–1863.
Sipahi I, Tuzcu EM, Schoenhagen P, Wolski KE, Nicholls SJ, Balog C et al. Effects of normal, pre-hypertensive, and hypertensive blood pressure levels on progression of coronary atherosclerosis. J Am Coll Cardiol 2006; 48 (4): 833–838.
Erdogan D, Yildirim I, Ciftci O, Ozer I, Caliskan M, Gullu H et al. Effects of normal blood pressure, prehypertension, and hypertension on coronary microvascular function. Circulation 2007; 115 (5): 593–599.
Aljefree N, Ahmed F. Prevalence of cardiovascular disease and associated risk factors among adult population in the Gulf region: a systematic review. Advances in Public Health 2015; 2015: e235101.
Acknowledgements
This study was conducted by Isfahan Cardiovascular Research Institute (WHO collaborating centre) and was supported the Department of Nutrition, the Ministry of Health and Medical Education in Iran.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Khosravi, A., Gharipour, M., Nezafati, P. et al. Pre-hypertension, pre-diabetes or both: which is best at predicting cardiovascular events in the long term?. J Hum Hypertens 31, 382–387 (2017). https://doi.org/10.1038/jhh.2016.42
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/jhh.2016.42
This article is cited by
-
The effect of prediabetes and diabetes on the incidence of cardiovascular disease in the population of 40 to 70 years in the south of Iran: a population-based cohort study
International Journal of Diabetes in Developing Countries (2024)
-
The burden of hypertension in Ecuador: a systematic review and meta-analysis
Journal of Human Hypertension (2021)
-
Sudden cardiac death among Iranian population: a two decades follow-up of Tehran lipid and glucose study
Scientific Reports (2021)
-
Stage 1 hypertension, but not elevated blood pressure, predicts 10-year fatal and non-fatal CVD events in healthy adults: the ATTICA Study
Journal of Human Hypertension (2019)